Presentation is loading. Please wait.

Presentation is loading. Please wait.

Disrupting and monitoring cancer cell viability using visualization and drug therapy Elinor Velasquez CS 261 Oct 21 2013.

Similar presentations


Presentation on theme: "Disrupting and monitoring cancer cell viability using visualization and drug therapy Elinor Velasquez CS 261 Oct 21 2013."— Presentation transcript:

1 Disrupting and monitoring cancer cell viability using visualization and drug therapy Elinor Velasquez CS 261 Oct 21 2013

2 Our motivation: Solve cancer Proposed way to solve cancer: Administer cancer-killing drugs (Phase I drugs) and immune system strengthening drugs (Phase II drugs) to a patient Issues: - Which drugs to use? - How do we know they are effective?

3 How visualization can address these issues Visualization can identify which drugs to use Interaction with visualization can provide scenarios for predicting drug therapy effectiveness Visualization can monitor a patient’s progress during drug therapy

4 CS 261 project: Implement visualization for phase I drugs Identify cancer-killing drugs for an individual patient Predict cancer-killing drug efficacy on patient before treating with the drug Monitor cancer-killing drug therapy response in patient

5 State of the art visualization of biological pathways Entourage (2013) Visualizes “focus nodes” which are genes with high standard deviation in data User manually selects subpaths based on focus nodes User selects drug by viewing its effect on gene (focus node) in that cell line

6 Our proposed project differs from Entourage We implement an algorithm that ranks (by activity) all subpaths in the pathway, based on a patient’s data, literature data, biochemical flux, path topology User interaction: Manual knocking out of alternative paths and getting cancer cell survival metric for that one patient pre-drug therapy Animation of patient’s samples taken over time of drug therapy that monitors progress of that patient User manually selects subpath of interest in cell line via focus gene No metric predicting cancer cell survival in a given patient No time-dependent or semantic attribute-dependent animation: static system Our visualizationEntourage

7 Our visualization is of metabolic (energy) pathways Cancer can be viewed as a metabolic disease Rank metabolic activity via patient genomic/proteomic data and biochemistry and topology of path Path activity ranking displayed using color Knock down/out edge or path(s) and get cancer cell survival score Monitor patient’s progress by animation of ranked paths per sample over time of drug therapy

8 Data chosen for visualization demonstration Study paths in the TCA cycle and glycolysis Two demos: Snapshot data from human brain cancer cell line and healthy brain sample Animation data from human lung cancer cells (9 time points collected over 72 hours) undergoing conversion to metastatic cells

9 Epilogue: How to cure a patient’s cancer using visualization and drug therapy Use animation on cancer data collections (and metabolic version of Entourage) to identify all drug classes for all cancers Given a patient’s genomic/proteomic data, use visualization to select drug for the patient. Ideally drug belongs to known drug class.


Download ppt "Disrupting and monitoring cancer cell viability using visualization and drug therapy Elinor Velasquez CS 261 Oct 21 2013."

Similar presentations


Ads by Google